Clinical Trials

cliniMACs HUD for T Cell Depletion

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Evaluation of Patients With Immune Function Abnormalities

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection

Targeting Real World Usage In Stroke Treatment

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1

A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

Gene Therapy for X Linked Severe Combined Immunodeficiency

Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1)

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

Molecular and Clinical Studies of Primary Immunodeficiency Diseases